BRAX Share Price Performance
Recent BRAX News & Updates
No updates
Braxia Scientific Corp. Key Details
Last Reported Earnings
Dec 31, 2023
Next Reporting Earnings
n/a
- Earnings per share (EPS)
- -0.034
- Gross Margin
- 14.67%
- Net Profit Margin
- -436.37%
- Debt/Equity Ratio
- -29.6%
Braxia Scientific Corp. Competitors
About BRAX
- Founded
- n/a
- Employees
- n/a
- CEO
- WebsiteView website
Braxia Scientific Corp. operates as a medical research company with clinics that provide ketamine treatments for persons with depression and related disorders. The company also owns and operates multidisciplinary clinics that offers treatment of mental health disorders. In addition, it is involved in the research activities related to discovering and commercializing novel drugs and delivery methods; and development and acquisition of derivatives of ketamine and psilocybin, as well as other psychedelic products from its IP development platform. The company is headquartered in Toronto, Ontario.
Canadian Market Performance
- 7 Days: 0.7%
- 3 Months: 11.2%
- 1 Year: 17.5%
- Year to Date: 10.6%
In the last week, the market has stayed flat, however the Healthcare sector stood out, gaining 3.8%. As for the longer term, the market has risen 18% in the past 12 months. As for the next few years, earnings are expected to grow by 12% per annum. Market details ›
Companies across the globe are beginning to pay attention to agentic AI. It’s also a term you’re likely to hear a lot during earnings season. In fact, it came up 26 times during...
Continue reading